C57BL/6-Gata6tm1(EGFP/cre/ERT2)Fmw/H

Status

Available to order

EMMA IDEM:08976
International strain nameC57BL/6-Gata6tm1(EGFP/cre/ERT2)Fmw/H
Alternative nameGata6cre (C57BL/6J)
Strain typeTargeted Mutant Strains : Knock-in
Allele/Transgene symbolGata6tm1(EGFP/cre/ERT2)Fmw,
Gene/Transgene symbolGata6

Information from provider

ProviderFiona Watt
Provider affiliationCentre for Stem Cell and Regenerative medicine, King
Genetic informationTamoxifen-inducible cre recombinase is expressed under endogenous Gata6 promoter. For the generation of the Gata6 eGFP-CreERT2 knock-in construct, an IKMC intermediate vector targeted on C57BL/6J BACs was used. A final targeting vector was constructed using gateway modular strategy as described in Skarnes et al. (Nature, 2011). The final vector was then electroplated into JM8 ES cells and selected for puromycin antibiotic resistance. Allelic targeting was determined in single clones by restriction digestion and sequencing of genomic DNA. The copy number was determined by qPCR probe against puromycin sequence. The final targeting allele would result in an eGFP-CreERT2 expression element targeted in-frame with the first non-coding exon of Gata6 gene and further frameshifting (Gata6-eGFPCreERT2). The mouse mutant has been generated to perform lineage tracing experiments or to create inducible conditional transgenic with floxed constructs. These allow to study Gata6 progeny. This gene is widely expressed and an inducible construct like this was not available yet. For this reason many other scientists will be interested on this new strain. Gata6 is an essential gene for embryonic development. This mouse line has to be maintained heterozygous because the CreER transgenic cassette we used leads to genetic loss of Gata6.
Phenotypic informationHomozygous:
Lethal

Heterozygous:
Viable
Breeding historyNew strain recently generated in MRC Harwell.
References
  • Wounding induces dedifferentiation of epidermal Gata6+ cells and acquisition of stem cell properties.;Donati Giacomo, Rognoni Emanuel, Hiratsuka Toru, Liakath-Ali Kifayathullah, Hoste Esther, Kar Gozde, Kayikci Melis, Russell Roslin, Kretzschmar Kai, Mulder Klaas W, Teichmann Sarah A, Watt Fiona M, ;2017;Nature cell biology;19;603-613; 28504705
Homozygous fertileno
Homozygous viableno
Homozygous matings requiredno
Immunocompromisedno

Information from EMMA

Archiving centreMary Lyon Centre at MRC Harwell, Oxford, United Kingdom
Animals used for archivingheterozygous C57BL/6J

Disease and phenotype information

Orphanet associated rare diseases, based on orthologous gene matching

Literature references

  • Wounding induces dedifferentiation of epidermal Gata6+ cells and acquisition of stem cell properties.;Donati Giacomo, Rognoni Emanuel, Hiratsuka Toru, Liakath-Ali Kifayathullah, Hoste Esther, Kar Gozde, Kayikci Melis, Russell Roslin, Kretzschmar Kai, Mulder Klaas W, Teichmann Sarah A, Watt Fiona M, ;2017;Nature cell biology;19;603-613; 28504705

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
MTA will be issued after an order has been submitted.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).